ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,575.90
-1.39%
S&P ASX All Technology
2,970.40
-1.25%
Brent Oil
88.165
0.02%
US Dollar vs AUD
1.53061
-0.16%
Bitcoin
63,961.81
-0.81%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. AC Immune SA (ACIU)

  7. AC Immune SA (ACIU) News

ACIU AC Immune SA

2.34
0.05 (2.18%)
After Hours
Last Updated: 06:07:11
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
AC Immune SA ACIU NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.05 2.18% 2.34 06:07:11
Open Price Low Price High Price Close Price Previous Close
2.30 2.25 2.4952 2.34 2.29
more quote information »

Recent News

Date Time Source Heading
10/2/202408:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/1/202423:53EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/1/202408:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/1/202400:10GLOBEAC Immune Progress Update on Phase 2 Active Immunotherapy..
29/12/202308:22EDGAR2Form 144 - Report of proposed sale of securities
20/12/202300:53EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/12/202309:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/12/202308:31EDGAR2Form 144 - Report of proposed sale of securities
15/12/202323:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202308:18EDGAR2Form 144 - Report of proposed sale of securities
07/12/202308:37EDGAR2Form 144 - Report of proposed sale of securities
01/12/202323:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/11/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/8/202306:17EDGAR2Form 144 - Report of proposed sale of securities
22/8/202306:23EDGAR2Form 144 - Report of proposed sale of securities
18/8/202306:15EDGAR2Form 144 - Report of proposed sale of securities
10/8/202306:16EDGAR2Form 144 - Report of proposed sale of securities
09/8/202306:20EDGAR2Form 144 - Report of proposed sale of securities
04/8/202321:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/7/202321:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/7/202306:22EDGAR2Form 144 - Report of proposed sale of securities
22/7/202306:08EDGAR2Form 144 - Report of proposed sale of securities
19/7/202306:09EDGAR2Form 144 - Report of proposed sale of securities
14/7/202306:23EDGAR2Form 144 - Report of proposed sale of securities
13/7/202306:07EDGAR2Form 144 - Report of proposed sale of securities
11/7/202306:15EDGAR2Form 144 - Report of proposed sale of securities
08/7/202306:14EDGAR2Form 144 - Report of proposed sale of securities
04/7/202303:23EDGAR2Form 144 - Report of proposed sale of securities
28/6/202303:30APSBiotech Pops On FDA Fast Track Designation
27/6/202322:11DJNAC Immunity Shares Jump 18% After Fast-Track Designation on..

Your Recent History

NASDAQ
ACIU
AC Immune
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved